Palantir: the aggregate is hiding the cohort
Total seats keep rising while the first enterprise cohort renews below plan. The blended number conceals that for roughly two more quarters.
Evidence · 5 cards
Discussion · 3
Good to see an invalidation level actually stated. The regulatory ceiling being quantified changes the model, not just the headline. How much of this do you think is already in the buy side's numbers?
Reasonable, and I have thought about it a lot. The comp table took longer than the rest of the piece put together, so I am glad it was the useful part.
Been long since the last one. The depreciation schedule really is the whole disagreement. Curious whether you would still size it the same at a higher entry.